PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard in The U.S. PLC Systems Inc. announced that it has received full approval from the U.S. Food and Drug Administration (FDA) for its U.S. pivotal trial to study the effectiveness of the Company's RenalGuard System and associated therapy in the prevention of Contrast-Induced Nephropathy (CIN). [more...]
